Trial Profile
The Safety and Immune Response to Influenza Vaccination in Pregnant Women.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Adimmune Corporation
- 13 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Jul 2012 Planned End Date added to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 27 Jan 2012 New trial record